2017 EASO实践建议:减重术后医学管理

2017-12-06 欧洲肥胖症研究学会 Obes Facts. 2017 Dec 6;10(6):597-632.

减重手术是目前严重肥胖患者长期治疗和管理的最有效的方法,其应用已经被成人肥胖管理指南推荐。通常来说,减重手术安全有效,但是可能导致新的临床问题,因此需要特殊的诊断,预防和治疗。本文主要针对减重术后的医学管理出指导建议,内容涉及营养管理,微量元素补充,共病管理,术后药物治疗,术后妊娠管理和体重增加的预防等。

中文标题:

2017 EASO实践建议:减重术后医学管理

英文标题:

Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management.

发布机构:

欧洲肥胖症研究学会

发布日期:

2017-12-06

简要介绍:

减重手术是目前严重肥胖患者长期治疗和管理的最有效的方法,其应用已经被成人肥胖管理指南推荐。通常来说,减重手术安全有效,但是可能导致新的临床问题,因此需要特殊的诊断,预防和治疗。本文主要针对减重术后的医学管理出指导建议,内容涉及营养管理,微量元素补充,共病管理,术后药物治疗,术后妊娠管理和体重增加的预防等。

 

拓展指南:减重相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 EASO实践建议:减重术后医学管理)] GetToolGuiderByIdResponse(projectId=1, id=f74431c00152968b, title=2017 EASO实践建议:减重术后医学管理, enTitle=Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management., guiderFrom=Obes Facts. 2017 Dec 6;10(6):597-632., authorId=null, author=, summary=减重手术是目前严重肥胖患者长期治疗和管理的最有效的方法,其应用已经被成人肥胖管理指南推荐。通常来说,减重手术安全有效,但是可能导致新的临床问题,因此需要特殊的诊断,预防和治疗。本文主要针对减重术后的医学管理出指导建议,内容涉及营养管理,微量元素补充,共病管理,术后药物治疗,术后妊娠管理和体重增加的预防等。 , cover=, journalId=null, articlesId=null, associationId=693, associationName=欧洲肥胖症研究学会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Dec 06 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>减重手术是目前严重肥胖患者长期治疗和管理的最有效的方法,其应用已经被成人肥胖管理指南推荐。通常来说,减重手术安全有效,但是可能导致新的临床问题,因此需要特殊的诊断,预防和治疗。本文主要针对减重术后的医学管理出指导建议,内容涉及营养管理,微量元素补充,共病管理,术后药物治疗,术后妊娠管理和体重增加的预防等。 </P> <P> </P>拓展指南:<strong>与<font color=red>减重</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=e58191c001a6e819" title="2017 共识指南:阻塞性睡眠呼吸暂停减重手术围术期管理" target=_blank>2017 共识指南:阻塞性睡眠呼吸暂停减重手术围术期管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=109f21c001a0e0e9" title="美国代谢与减重手术学会2016年最新立场声明解读" target=_blank>美国代谢与减重手术学会2016年最新立场声明解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=74ed81c001220391" title="2015 ASGE指南:内镜检查在减重手术患者中的作用" target=_blank>2015 ASGE指南:内镜检查在减重手术患者中的作用</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=56a311c0009e1002" title="AACE/TOS/ASMBS临床实践指南:减重手术患者的围手术期营养、代谢和非手术支持(2013更新)" target=_blank>AACE/TOS/ASMBS临床实践指南:减重手术患者的围手术期营养、代谢和非手术支持(2013更新)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=00e421c00082694d" title="2011 IDF 减重手术治疗肥胖伴2型糖尿病的立场声明" target=_blank>2011 IDF 减重手术治疗肥胖伴2型糖尿病的立场声明</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%87%8F%E9%87%8D" target=_blank>有关减重更多指南</a></ul>, tagList=[TagDto(tagId=1494, tagName=减重手术), TagDto(tagId=65235, tagName=术后管理)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4863, appHits=95, showAppHits=0, pcHits=3176, showPcHits=2181, likes=217, shares=3, comments=12, approvalStatus=1, publishedTime=Sat Dec 09 23:02:54 CST 2017, publishedTimeString=2017-12-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Dec 09 23:02:54 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:10:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 EASO实践建议:减重术后医学管理)])
2017 EASO实践建议:减重术后医学管理
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954684, encodeId=4d62954684dc, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:38:26 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888864, encodeId=cc7f888864e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Mon Sep 28 10:45:59 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806983, encodeId=6f0a80698304, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=568f2273884, createdName=瓜虫, createdTime=Sat Aug 08 19:17:38 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268332, encodeId=b62d268332b8, content=学习了.谢谢., beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 10 10:01:51 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268311, encodeId=95472683116f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Dec 10 08:42:34 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好,但无法分享,遗憾!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954684, encodeId=4d62954684dc, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:38:26 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888864, encodeId=cc7f888864e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Mon Sep 28 10:45:59 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806983, encodeId=6f0a80698304, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=568f2273884, createdName=瓜虫, createdTime=Sat Aug 08 19:17:38 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268332, encodeId=b62d268332b8, content=学习了.谢谢., beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 10 10:01:51 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268311, encodeId=95472683116f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Dec 10 08:42:34 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
    2020-09-28 Ably冰

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=954684, encodeId=4d62954684dc, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:38:26 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888864, encodeId=cc7f888864e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Mon Sep 28 10:45:59 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806983, encodeId=6f0a80698304, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=568f2273884, createdName=瓜虫, createdTime=Sat Aug 08 19:17:38 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268332, encodeId=b62d268332b8, content=学习了.谢谢., beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 10 10:01:51 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268311, encodeId=95472683116f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Dec 10 08:42:34 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
    2020-08-08 瓜虫

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=954684, encodeId=4d62954684dc, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:38:26 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888864, encodeId=cc7f888864e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Mon Sep 28 10:45:59 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806983, encodeId=6f0a80698304, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=568f2273884, createdName=瓜虫, createdTime=Sat Aug 08 19:17:38 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268332, encodeId=b62d268332b8, content=学习了.谢谢., beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 10 10:01:51 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268311, encodeId=95472683116f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Dec 10 08:42:34 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
    2017-12-10 惠映实验室

    学习了.谢谢.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=954684, encodeId=4d62954684dc, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:38:26 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888864, encodeId=cc7f888864e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/567eec2d6b074163be1d5e1d9226b578/9c20a5fef2764c169c6ac9bf44997ee8.jpg, createdBy=7d5a5410735, createdName=Ably冰, createdTime=Mon Sep 28 10:45:59 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806983, encodeId=6f0a80698304, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=568f2273884, createdName=瓜虫, createdTime=Sat Aug 08 19:17:38 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268332, encodeId=b62d268332b8, content=学习了.谢谢., beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sun Dec 10 10:01:51 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268311, encodeId=95472683116f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Dec 10 08:42:34 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
    2017-12-10 神功盖世

    学习

    0